A DNA methyltransferase 3A (DNMT3A)/AGO4 complex abolished miR-181-5p inhibition of gene expression via the cytosine methylation of miR-181-5p and resulted in an aggressive outcome of a glioblastoma multiforme (GBM) [44]. The gene discussed is DNMT3A; the disease is glioblastoma.